$PTGX
Protagonist Therapeutics, Inc
XNAS•Health Care•Pharmaceutical Preparations
$143.00
▼-0.49%-$0.700
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateProtagonist Therapeutics, Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is PTGX down today? It is at $143.00 (-0.49%), and our scanner flagged it 46 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PTGX spikes, and full due diligence on PTGX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PTGX 46 times in the last 30 days. Create a free account to track $PTGX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PTGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PTGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -7K 0.01% of company | sold 1.4% | 523K | $1.0M at $144.10 | Sep 10, 26 |
Patel Dinesh V Ph D Officer | Other | 7K 0.01% of company | added 1.4% | 530K | $157K at $21.58 | Sep 10, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -64K 0.10% of company | sold 11% | 523K | $9.3M at $146.18 | Sep 9, 26 |
Patel Dinesh V Ph D Officer | Other | 64K 0.10% of company | added 12% | 587K | $1.4M at $21.58 | Sep 9, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -54K 0.08% of company | sold 9.4% | 523K | $7.9M at $145.87 | Sep 8, 26 |
Patel Dinesh V Ph D Officer | Other | 54K 0.08% of company | added 10% | 577K | $1.2M at $21.58 | Sep 8, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -510 | sold <0.1% | 523K | n/a | Sep 3, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -34K 0.05% of company | sold 6.1% | 523K | $5.1M at $148.52 | Aug 11, 26 |
Patel Dinesh V Ph D Officer | Other | 34K 0.05% of company | added 6.5% | 558K | $739K at $21.58 | Aug 11, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -66K 0.1% of company | sold 11% | 523K | $9.8M at $149.11 | Aug 10, 26 |
Patel Dinesh V Ph D Officer | Other | 66K 0.1% of company | added 13% | 589K | $1.4M at $21.58 | Aug 10, 26 |
Waddill William D. Director | Sold (automatic/other) | -9K 0.01% of company | sold 53% | 8K | $1.1M at $117.94 | Jun 23, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PTGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PTGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PTGX last traded at $143.00, down 0.49% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Protagonist Therapeutics, Inc (PTGX) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PTGX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PTGX 46 times in the last 30 days.
PTGX (Protagonist Therapeutics, Inc) trades on XNAS, with a market cap of about $9.25B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PTGX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PTGX discussion
Sign in to ask a question or join the discussion.